These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36246001)

  • 1. Is a Preservation Solution for Living Donor Liver Transplantation Needed? Adding a New Chapter in LDLT!
    Dogar AW; Ullah K; Shams-Ud-Din ; Abbas SH; Hussain A; Ghaffar A; Bilal H; Siraj-Ud-Din ; Shoaib A; Ahmed B; Raza H; Hamza A; Hafeez Bhatti AB; Gupta S; Black SM; Mumtaz K
    Transplant Direct; 2022 Nov; 8(11):e1396. PubMed ID: 36246001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: A propensity score matching analysis from mainland China.
    Xu X; Zhu YF; Lv T; Zheng JL; Li YK; Zhang BH; Jiang L; Yang JY
    Medicine (Baltimore); 2020 Dec; 99(51):e23584. PubMed ID: 33371088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of living donor liver preservation with HTK solution.
    Ringe B; Braun F; Moritz M; Zeldin G; Soriano H; Meyers W
    Transplant Proc; 2005; 37(1):316-9. PubMed ID: 15808629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical assay for hepatic grafts preservation with University of Wisconsin or histidine-tryptophan-ketoglutarate solutions in liver transplantation.
    Meine MH; Zanotelli ML; Neumann J; Kiss G; de Jesus Grezzana T; Leipnitz I; Schlindwein ES; Fleck A; Gleisner AL; de Mello Brandão A; Marroni CA; Cantisani GP
    Transplant Proc; 2006; 38(6):1872-5. PubMed ID: 16908310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in adult liver transplantation.
    Rayya F; Harms J; Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2008 May; 40(4):891-4. PubMed ID: 18555073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation.
    Nardo B; Bertelli R; Montalti R; Beltempo P; Puviani L; Pacilè V; Cavallari A
    Transplant Proc; 2005; 37(1):320-2. PubMed ID: 15808630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. University of Wisconsin versus histidine-tryptophan-ketoglutarate for tissue preservation in live-donor liver transplantation.
    Jain A; Mohanka R; Orloff M; Abt P; Kashyap R; Cullen J; Lansing K; Bozorgzadeh A
    Exp Clin Transplant; 2006 Jun; 4(1):451-7. PubMed ID: 16827642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outcomes using two preservation solutions (UW/HTK) in liver transplantation from brain death donors].
    Martínez J; Bächler JP; Moisan F; Torres J; Duarte I; Pérez RM; Benítez C; Arrese M; Domínguez P; Guerra JF; Jarufe N
    Rev Med Chil; 2014 Oct; 142(10):1229-37. PubMed ID: 25601106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience.
    Gulsen MT; Girotra M; Cengiz-Seval G; Price J; Singh VK; Segev DL; Cameron AM; Gurakar A
    Ann Transplant; 2013 Feb; 18():69-75. PubMed ID: 23792504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Flush With Histidine-Tryptophan-Ketoglutarate and University of Wisconsin Solutions in Liver Transplantation: Preliminary Results.
    León Díaz FJ; Fernández Aguilar JL; Nicolás de Cabo S; Pérez Reyes M; Sánchez Pérez B; Montiel Casado C; Pérez Daga JA; Aranda Narváez JM; Suárez Muñoz MA; Arenas González F; Florez Rías MM; Pelaez Angulo JL; Santoyo Santoyo J
    Transplant Proc; 2018 Mar; 50(2):539-542. PubMed ID: 29579846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.
    Pirenne J; Van Gelder F; Coosemans W; Aerts R; Gunson B; Koshiba T; Fourneau I; Mirza D; Van Steenbergen W; Fevery J; Nevens F; McMaster P
    Liver Transpl; 2001 Jun; 7(6):540-5. PubMed ID: 11443584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Direct Comparison Between Institut Georges Lopez 1 and Histidine-Tryptophan-Ketoglutarate Preservation Solutions in Liver Transplantation.
    Kiyoshi Takano de Saidneuy AE; Bruno de Rezende M; Rogerio de Oliveira Salvalaggio P
    Transplant Proc; 2020 Jun; 52(5):1262-1264. PubMed ID: 32507487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantation.
    Hatano E; Kiuchi T; Tanaka A; Shinohara H; Kitai T; Satoh S; Inomoto T; Egawa H; Uemoto S; Inomata Y; Lang H; Oldhafer KJ; Ringe B; Pichlmayr R; Tanaka K; Yamaoka Y
    Clin Sci (Lond); 1997 Jul; 93(1):81-8. PubMed ID: 9279207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors.
    Mangus RS; Fridell JA; Vianna RM; Milgrom MA; Chestovich P; Chihara RK; Tector AJ
    Liver Transpl; 2008 Mar; 14(3):365-73. PubMed ID: 18306380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison Between IGL-1 and HTK Preservation Solutions in Deceased Donor Liver Transplantation.
    Meine MH; Leipnitz I; Zanotelli ML; Schlindwein ES; Kiss G; Martini J; de Medeiros Fleck A; Mucenic M; de Mello Brandão A; Marroni CA; Craco Cantisani GP
    Transplant Proc; 2015 May; 47(4):888-93. PubMed ID: 26036479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation.
    Potdar S; Malek S; Eghtesad B; Shapiro R; Basu A; Patel K; Broznick B; Fung J
    Clin Transplant; 2004 Dec; 18(6):661-5. PubMed ID: 15516240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type of Preservation Solution, UW or HTK, Has an Impact on the Incidence of Biliary Stricture following Liver Transplantation: A Retrospective Study.
    Karakoyun R; Romano A; Nordström J; Ericzon BG; Nowak G
    J Transplant; 2019; 2019():8150736. PubMed ID: 31934445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
    Zimmerman MA; Baker T; Goodrich NP; Freise C; Hong JC; Kumer S; Abt P; Cotterell AH; Samstein B; Everhart JE; Merion RM
    Liver Transpl; 2013 Mar; 19(3):259-67. PubMed ID: 23495079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antegrade Hepatic Artery and Portal Vein Perfusion Versus Portal Vein Perfusion Alone in Living Donor Liver Transplantation: A Randomized Trial.
    Shaji Mathew J; Kumar KYS; Nair K; Thankamony Amma BSP; Krishnakumar L; Balakrishnan D; Gopalakrishnan U; Menon RN; Sunny A; Dhar P; Othiyil Vayoth S; Surendran S
    Liver Transpl; 2019 Sep; 25(9):1353-1362. PubMed ID: 30908879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.